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ABSTRACT 
Flavones are polyphenol natural products that are known to have neuroprotective effects 
against many diseases caused by the formation of reactive species. Flavonoids are subgroup of 
flavones and they are believed to function as antioxidants. Specifically, they target free radicals 
and eliminate its harmful effect on the cell. 
Fluoroflavones were designed to improve the potency of the antioxidant activity and 
potentially be used as neuroprotective agents. A monofluorinated and trifluoromethylated flavone 
were synthesized by using commercially available fluorination reagents, N-
fluorobenzenesulfonimide; and Togni’s or Umemoto's respectively. After the synthesis of the 
desired flavones and their monofluorinated and trifluoromethylated derivatives, biological testing 
was conducted. First, antioxidant activity was evaluated by using DPPH antioxidant assay and 
displayed that the fluorinated flavones are more potent compared to their non-fluorinated 
derivatives. Second, 19F NMR experiments were conducted to investigate the effect of fluorination 
on the antioxidant activity of flavones  
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CHAPTER 1 
INTRODUCTION 
1.1 Flavonoid:  
Polyphenols are secondary metabolites found in many plants. All characterized by the 
presence of phenol rings, and they can be subdivided to two main classes depending on their 
structure; flavonoid and non-flavonoid. The non-flavonoid includes: stilbenes, lignans and 
phenolic acids, which can be further divided into two main types, benzoic acid and cinnamic acid, 
while flavonoids are subdivided into six main types which will be discussed later. [1] 
 
 
 
1.1.1 Flavones: A Polyphenol Natural Product: 
Flavones are a subgroup of flavonoids, which are synthesized in plants from three building 
blocks phenylalanine, tyrosine, and malonate [2]. The general structure of flavonoids consists of 
three six-membered rings, two aromatic carbon rings, benzopyran (A and C rings) and benzene (B 
ring), that vary in the degree of oxidation and substitutions (Figure 1). Flavonoids can be divided 
into six subgroups based on the degree of the oxidation of ring C. The main subgroups are (1) 
flavonols, (2) flavones, (3) isoflavones, (4) flavanones, (5) flavanols, and (6) anthocyanidins as 
shown in (Figure 2). [3]
Figure 1.1: Basic structure of flavonoids. 
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Flavonoids are generally found in vegetables and fruits like apples, cauliflower, and 
carrots, and also in beverages like tea, coffee and red wine. Flavonoids give fruits, flowers and 
even the leaves different shades of color which will help the plant to attract pollinating insects, 
and in contrast, flavonoids can have a protective response to harmful insects. Because of their 
ability to absorb UV radiation, flavonoids can absorb the harmful sun radiation and function as 
catalysts in many photosynthesis processes. [4]  
The total dietary intake of flavonoids as antioxidants range between 50 and 1000 mg/day, 
which is very high when compared to other natural antioxidants like vitamin C and vitamin E, that 
are around 10 and 100 higher than flavonoids daily dose, respectively. [5] Flavonoids can be 
absorbed in many forms, either with the glycosides or without it, or even as phenolic acids. All of 
the three forms have antioxidant activity in different degrees.   
 
Figure 1.2: Classes of flavonoids. 
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1.1.2 Metabolism of Flavones 
In general, flavonoids undergo extensive metabolism by methylation, glucuronidation or 
sulfation; due to the several hydroxyl groups found in their structures. This rapid metabolism 
affects its absorption after oral administration. Fortunately, one of these enzymatic pathways ( O-
methylation ) will increase the stability and distribution of flavonoids and hence increase their 
bioavailability [5]. The majority of flavones in plants are found conjugated as 7-O-glycosides, and 
the metabolic transformations will effect both the glycone moiety and the aglycone flavone. The 
major metabolic conversions are: 1) conversion of flavone 7-O-glucoside to flavone aglycone by 
lactase-phlorizin hydrolase (LPH) in small intestine, 2) conversion of flavone aglycone to flavone 
glucuronide by UDP-glucuronosyltransferase (UGT) in both liver and small intestine, 3) 
conversion of aglycone flavone to the flavone sulfate by sulfotransferase in the liver, and 4) 
conversion of flavone 7-O-glucoside to flavone aglycone and 3-(4-hydroxyphenyl) propionic acid 
by normal flora of large intestine (Figure 3). [6] 
 
4 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Metabolism of flavones   
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1.1.3 Flavones as antioxidants:   
Flavonoids display three key structural features in order to function as radical scavenger; 
ring B must have a catechol group, ring C must have a 2,3-double bond in conjugation with a 4-
oxo group, ring A must have two hydroxy groups at 3- and 5. All the previous points are 
responsible for electron delocalization that is necessary to stabilize the free radicals [7] (Figure 1.4). 
It was reported that flavonoids function as antioxidants by a radical scavenging mechanism. 
Although this is true in vitro, a different mechanism is has been proposed in vivo. Ursini suggested 
that flavonoids induce endogenous antioxidant activity by a signaling pathway rather that radical 
scavenging. [8] This pathway involves oxidative activation of the NF-E2-related factor. It has been 
reported that radical scavenging is not as effective in vivo when it’s compared with other stronger 
endogenous antioxidants. [8] 
 
 
 
 
 
 
 
 
 
Figure 1.4: Structure of flavone. 
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1.2 Oxidation:  
In chemistry, oxidation is defined as the removal of electrons from one reactant to another. 
Oxidation is always linked with reduction reactions and are usually referred as redox reactions. In 
biology, the same concept is applied. [9] 
1.2.1 Oxidants:  
  
Reactive species belong to two types of reactive molecules: reactive oxygen species (ROS) 
and reactive nitrogen species (RNS). The term ROS include both free radical and non-free radical 
species like hydrogen peroxide, molecular oxygen, and ozone. [10] ROS is a normal byproduct in 
many aerobic metabolisms and is regulated by NADPH. [11] It has an essential function in cellular 
signaling and communications. Damage to cellular tissue may occur when the intracellular level 
of ROS is elevated, which is known by oxidative stress.  
 
1.2.2 Antioxidants:  
An antioxidant is a nucleophilic reductant that prevents oxidation of an another molecule, 
either by reducing the free radicals or preventing their formation. [9] It can be endogenous and 
exogenous. The endogenous include two main categories which are both complementary to 
enzymatic and non-enzymatic defenses. The enzymatic defenses are enzymes that prevent the 
formation of free radicals by metabolizing reactive oxygen species like hydrogen peroxide, 
superoxide, oxygen singlet, and lipid peroxides. Examples of antioxidant enzymes include Cu/Zn-
superoxide dismutase, catalase, Se-glutathione peroxidase and glutathione reductase. [2] The non-
enzymatic defenses can inactivate free radicals immediately, and they are further subdivided into 
intracellular and extracellular processes. The most common ones are the metal-binding proteins 
(MBPs), coenzyme Q10 (CoQ10), glutathione (GSH), uric acid (UA) and melatonin (MEL).   
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The question is, how these different types of antioxidant complement each other? The 
answer is summarized in the first, second, and third line of defenses against ROS. [12] The first line 
is the most powerful one and it includes both enzymatic and non-enzymatic defenses. Each one of 
these antioxidant functions in a distinctive manner. The Cu/Zn-superoxide dismutase is a 
metalloenzyme that catalyzes the disproportionation (simultaneously oxidization and reduction) 
of superoxide free radical (O2•–) to form hydrogen peroxide and molecular oxygen (Table 1.1). 
Another enzymatic defense is  catalase (CAT) which is a heme-containing enzyme that can 
covert hydrogen peroxide to molecular oxygen and water in a two-step reaction, a reduction and 
oxidation.[13] Furthermore, Se-glutathione peroxidase is a selenoenzyme in which hydrogen 
peroxide is reduced to water and glutathione (GSH) is oxidized to the glutathione disulfide 
(GSSG). [14]  
The other part of the first line defenses is the non-enzymatic substances which are proteins 
that inhibit the formation of free radicals by transition metal ion binding mechanism, examples 
include, albumin ceruloplasmin and ferritin. Those non-enzymatic substances that have the ability 
to rapidly inactivate free radicals, like coenzyme Q10 (CoQ10), glutathione (GSH), uric acid (UA) 
and melatonin (MEL). The third line of defense is the repairing step which involve enzymatic 
antioxidants that will repair the damage generated by free radicals in DNAs, proteins, cell 
membrane and other cell organelles. [9] 
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Name of the enzyme Main target The resulted reaction 
Cu/Zn-superoxide dismutase superoxide free radical 2 HO2 → O2 + H2O2 
Catalase hydrogen peroxide 2 H2O2 → 2 H2O + O2 
Se-glutathione peroxidase hydrogen peroxide 2GSH + H2O2 → GS–SG + 2H2O 
 
Endogenous antioxidants are known to be stronger than exogenous ones, but the balance 
between ROS and antioxidants is always changing. In other words, oxidative stress is happening, 
whether the cause was from internal factors like inflammation or cancer or external factors like 
environmental pollutants such as smoking, radiations or even metals. Also, normal factors like 
aging can affect oxidation state. The need for exogenous antioxidants is to support the endogenous 
antioxidants and prevent any possible damage generated by the free radicals is clear. Exogenous 
antioxidants are substances that can be found in diet or from certain supplements. The most 
common exogenous antioxidant are vitamins like vitamin E and vitamin C, and polyphenols, like 
flavonols, flavones, and anthocyanidins. Most the dietary antioxidant can be found in fruits, 
vegetables and fruit-based beverages line wine and tea.  
 
 
 
 
 
 
 
Table 1.1: Main endogenous antioxidant. 
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1.3. Fluorine in Medicinal Chemistry 
Introducing a fluorine atom into a biologically active molecule is known to produce a 
significant impact. It is believed that 25% of drugs in the pharmaceutical market contain at least 
one fluorine atom. [15] Having high electronegativity and a small molecular size makes fluorine 
atom valuable in drug design. [16] Hydrogen and fluorine have similar molecular size, which makes 
fluorine a good alternative for the strict requirements at enzyme receptor sites, [17] even though 
their Van Der Waals radii are not similar (F = 1.47 Å, H = 1.20 Å). [18] In addition, fluorine often 
increases lipophilicity and therefore improves the pharmacokinetics properties like absorption and 
distribution [17] and enhances binding affinity. [16] 5-Fluorouracil (Efudex®) is one of the oldest 
fluorinated drugs (Figure 1.5). This antineoplastic agent was synthesized by Heidelberger in 1957 
and function by interfering with the synthesis of thymidylate. [15]  
Another well-known example of fluorine containing drugs is the antidepressant fluoxetine 
which was approved by the Food and Drug Administration (FDA) in 1987. Fluoxetine (Prozac®) 
contains a trifluoromethyl group in the para-position of the phenol ring. The structure–activity 
relationship indicates that the addition of trifluoromethyl increases the selectivity for the serotonin 
receptor by 6-fold when compared to the non-fluorinated parent compound. [15] 
 
 
 
 
 
Figure 1.5: Structure of 5-fluorouracil  Figure 1.6: Structure of fluoxetine 
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1.4. Fluorinated Flavonoids 
Flavones are fluorinated to increase their potency by preventing the extensive 
metabolism, like methylation, glucuronidation or sulfation. Many fluorinated flavonoids have 
been the synthesized by using a variety of methods. A fluoroflavone can be accessed by using 
acetophenone derivatives as starting materials followed by electrophilic or radical fluorination. 
[16] The other method involves the use of elemental fluorine on a flavone followed by 
dehydrofluorinaion to the monofluoroflavone by adsorbing the intermediate on a silica gel 
(scheme 1.2).  
 
 
 
 
 
 
 
 
 
Scheme 1.1: Fluorination of flavone by using fluorinating reagents.  
Scheme 1.2: Fluorination of flavone by using elemental fluorine. [15] 
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1.4.1 Monofluorinated Flavone 
Many fluorinated flavones has been synthesized and tested in the literature. One example 
is the work of Vanotti in which the 3-fluorotetrahydroxy flavone was synthesized and tested 
against cancer as telomerase inhibitors. The fluorinated flavone displayed a 13-fold reduction in 
IC50 for inhibition of telomerase activity compared to the non-fluorinated molecule. The IC50 of 3-
fluorotetrahydroxy flavone was 0.6 μM while for 3',4',7,8-tetrahydroxyflavone it 7.8 μM. [20]   
 
 
 
The 3-fluorotetrahydroxy flavone was synthesized by reacting N-
fluorobenzenesulfonimide with the diketone intermediate in anhydrous dichloromethane for seven 
days to afford the product in 28% yield. The mono-fluorinated intermediate was then cyclized by 
refluxing in acidic conditions to give the product in 82% yield. Compound 4 was demethylated by 
using boron tribromide in dichloromethane in 71% yield. (scheme 1.3) 
 
 
 
Figure 1.7: Structure of 3',4',7,8-tetrahydroxyflavone and 3',4',7,8-tetrahydroxyfluoroflavone 
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Scheme 1.3: Synthesis of monofluorinated flavone 
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1.4.2 Trifluoromethylated Flavone 
There is only one reported trifluoromethylated flavone derivative in the literature by Qing 
and co-workers in 2005, in which they synthesized the trifluoromethylated flavone by 
trifluoromethylation of 3-iodoflavonoid derivatives with methyl 2,2-difluoro-2-(fluorosulfonyl) 
acetate and copper iodide as catalyst (Scheme 1.4). [21]  Qing and co-workers also 
trifluoromethylate the flavone using trimethyl (trifluoromethyl) silane, also known as Ruppert's 
reagent tetramethylammonium fluoride as catalyst. The intermediate was then treated with 
hydrochloric acid (Scheme 1.5). [21]    
 
 
 
 
 
 
 
 
 
 
Scheme 1.4: Synthesis of trifluoromethylated flavone 
Scheme 1.5: trifluoromethylation the flavone 
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CHAPTER 2 
SYNTHESIS OF FLAVONOIDS AND FLUORINATED FLAVONOIDS 
2.1 Design strategy: 
The retrosynthesis of flavone is carried out by an intermolecular cyclization of compound 
4, followed by intermolecular rearrangement of compound 3. This arrangement is known as Baker-
Venkataraman reaction which involves a reaction of compound 3 with base to form a 1,3-diketone. 
The last step is a simple coupling of compound 1 with 2 under basic conditions (Scheme 2.1). 
 
+  
 
 
Scheme 2.1: The retrosynthesis of flavone 
15 
 
2.2 Flavonoid synthesis: 
The synthesis of the desired flavone compound 4 starts with two commercially available 
staring materials, compound 1 (2'-hydroxyacetophenone) and compound 2 (3,4,5-
trimethoxybenzoyl chloride) according to Vanotti )Scheme 2.2). [20] Coupling compound 1 with 
compound 2 in pyridine results in forming the ester 3 in 40% yield. Then, treating the ester 3 with 
potassium hydroxide forms the di-ketone 4, by a Baker-Venkataraman rearrangement. [16] 
Cyclization of compound 4 by refluxing with acetic acid and hydrochloric acid and demethylation 
by using boron tribromide provides the target flavone 6 (Scheme 2.2).  
 
+  
 
 
 
 
 
 
Schemes 2.2: Route toward the desired flavone 6 
16 
 
There are limited number of methods that are available for selective carbon-fluorine bond 
formation when compared to other carbon-halogen bond forming reactions. [18] We have two 
targets, which are the monofluorination and trifluoromethylation products. Both require 
electrophilic fluorinating reagents, and then cyclization to the targeted flavone (Scheme 2.3). 
 
 
 
 
 
 
 
 
Scheme 2.3: Fluorination and trifluoromethylation approaches 
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2.3.Monofluorination:  
N-Fluorobenzenesulfonimide (NFSI) was reported by Barnette in 1984. [18] This 
electrophilic fluorinating reagent is stable, easily prepared and purified. [24]  The monofluorinated 
flavone 10 was synthesized by reacting compound 4 with NFSI for a week in dichloromethane or 
in a mixture of dichloromethane and acetonitrile with a yield of 28% and 37% respectively. This 
method uses pyridine as a solvent. We screened different temperatures to observe the selectivity 
and reactivity of NFSI with the diketone 4. As the temperature increased from 0 °C to 50 °C  more 
of the mono-fluorinated diketone 10 is observed compared to di-fluorinated diketone 11. At 
100 °C, only the cyclized fluorinated form 12 is observed which give us a more efficient and direct 
method to access the final product. The yield increased from 32% to 72% and the reaction time 
decreased from 7 days to 12 h (Scheme 2.4 and Table 2.4). 
 
 
Entry Temperature  19F NMR ratio  
10 11 12 
1 0 °C 1  2.4 - 
2 24 °C 1  2.2 - 
3 50 °C 1 - 0.1 
4 100 °C - - 1 
Table 2.1: Fluorination of diketone intermediate with NFSI   
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Scheme 2.4: Route toward the desired monofluorinated flavone 
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2.4. Trifluoromethylation 
Togni I, 1-(trifluoromethyl)-1,2- benziodoxol-3(1H)-one, and Togni II, trifluoromethyl-
1,3-dihydro- 3,3-dimethyl-1,2-benziodoxole, are two hypervalent iodine species that function as a 
source of an electrophilic trifluoromethyl group (Figure 2.1). Togni’s reagent needs to be activated 
first by Lewis acids, Brønsted acids or even metals. Copper iodide was selected because it is one 
of the most widely used catalysts for activating of Togni’s reagents. [25] 
 
 
 
 
First, we tried to trifluoromethylate the protected β-diketone 7 with Togni I and copper 
iodide in THF or pyridine, with bases like LDA or BDU, or without any base. None of the reactions 
produced the target 9. So we repeated the same process with the unprotected  β-diketone 4, which 
also did not work. Umemoto’s reagent also failed to yield the desired product 9 or 14. 
 
 
Figure 2.1: Structures of Togni’s reagents 
Scheme 2.5: Fluorination of the protected β-diketone intermediate with Togni’s reagent 
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Entry Solvent 
(1 mL) 
Reagent 
[1.2] 
Activating 
Agent 
Base Temperatur
e (°C) 
Time 
(h) 
1 pyridine  Togni’s I  Cul [0.2] DBU  rt 24 
2 pyridine  Togni’s I  Cul [0.2] ــــــ  rt 24 
3 CH3CN  Togni’s II  Cul [0.2] ــــــ  40 12 
4 CH3CN  Togni’s II  Cul [0.2] ــــــ  rt 24 
5 EtOAc  Togni’s II  TBAI [0.1] ــــــ  80 24 
1 CH2Cl2 Umemoto's Cul [0.2] DBU 
 
rt 24 
2 CH2Cl2 Umemoto's Cul [0.2] ــــــ 
 
rt 24 
3 pyridine Umemoto's Cul [0.2] ــــــ 
 
40 12 
4 DMF Umemoto's TBAI 
[0.05] 
K2CO3 [3] rt 24 
5 DMF Umemoto's TBAI 
[0.05] 
K2CO3 [3] 40 24 
Table 2.2: Synthesis of fluorinated β-diketone intermediate  
 
Scheme 2.6 Synthesis of fluorinated β-diketone intermediate with Togni’s reagent 
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None of the previous experiment listed in (Table 2.2) led to the formation of the 
trifluorinated products. Another approach was taken using trifluoroiodomethane gas in a radical 
trifluoromethylation mechanism reagent, but again the reaction was not successful due to non-
selective fluorination (Scheme 2.7). The last approach was to trifluoromethylate a flavone by using 
Umemoto′s reagent or Togni I and copper iodide in dimethylformamide as seen in Scheme 2.8. [26] 
This method resulted in the trifluoromethylation of the flavone in 20% 19F NMR yield. Based on 
this finding, the desired methoxy flavone will be trifluoromethylated in the same fashion. The last 
step will involve refluxing the trifluoromethylated flavone using hydrobromic acid to afford the 
trihydroxyphenly flavone (Scheme 2.9). 
 
 
 
 
 
 
 
 
Scheme 2.7: Radical trifluoromethylation by using trifluoroiodomethane gas 
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Scheme 2.9: Trifluoromethylation of flavone by using Umemoto′s or Togni′s reagent then  
demethylation with hydrobromic acid 
Scheme 2.8: Trifluoromethylation of flavone by using Umemoto′s and Togni′s reagent 
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CHAPTER 3 
BIOLOGICAL EVOLUTION OF THE FLUORINATED FLAVONOIDS 
3.1 The DPPH antioxidant assay  
1,1-Diphenyl-2-picryl-hydrazyl (DPPH) is a free radical that is stable at room temperature 
and is a common reagent in an antioxidant assay based on electron-transfer mechanism. DPPH, 
produces a violet solution but when it is reduced in the presence of an antioxidant, DPPH will turn 
colorless. [27] The DPPH antioxidant assay is performed by using a 96-well plate and measure the 
scavenging activity toward the 2,2-diphenyl-1-picrylhydrazyl free radical. Many studies are 
conducted to measure the antioxidant activity of flavonoids using DPPH assay. [7,4]  
Mira and co-workers measured the antioxidant activity of various flavonoids against DPPH 
radical. The flavones myricetin, quercetin, kaempferol, and luteolin were tested. Flavone and 
DPPH were mixed for 30 min then absorbance measured at 517 nm. The results are summarized 
in Table 4 and indicated how scavenging activity increases with increasing the number of the free 
OH group (Table 3.1). [28]
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Flavones 
 
Structure 
Mmol DPPH scavenged per 
mmol flavonoid 
 
 
Myricetin 
 
 
 
5.7 ± 0.3 
 
 
Quercetin 
 
 
2.9 ± 0.1 
 
 
Luteolin 
 
 
2.7 ± 0.1 
 
 
Kaempferol 
 
 
2.2 ±0.2 
 
 
 
 
  
 
 
 
 
Table 3.1: DPPH scavenging activity of hydroxy-flavones 
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3.1.1 Results  
The scavenging activity of flavones 5 and 6 and their monofluorinated derivatives 12 and 
13 in concentration ranging from (1.5625 – 200 μg/mL) were evaluated against 0.1 mM of DPPH 
by the decrease of absorbance at 517 nm. The data indicate that the monofluorinated flavones are 
more potent than the un-fluorinated derivatives. For example, the EC50 of 6 dropped from 37.14 
μg/mL to 0.2359 μg/mL for the fluorinated 13. Also, the EC50 of the methoxy flavone 5 dropped 
from 71.66 to 0.3345 μg/mL when compared with the fluorinated methoxy flavone 12 (Table 
4.2) and (Figure 3.1). 
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Compound EC50 ± SD (μg/mL) 
 
 
 
71.66 ± 0.04 
 
 
 
37.14 ± 0.02 
 
 
 
0.3345 ± 0.017 
 
 
 
0.2359 ± 0.035 
 
 
 
0.1596 ±0.034 
 
 
 
Table 3.2: Flavones used in DPPH assay and their EC50 values.  
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Figure 3.1: DPPH assay results    
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3.2 neuroprotective assay 
neuroprotective assay is used to measure the cell viability in response to many substrates 
like growth factors, cytokines and cytotoxic reagent. In our case we will be testing the synthesized 
flavones and their fluorinated derivatives. This assay is based on the reduction of the 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) 
tetrazolium compound by viable mammalian cells (neurons) to generate a colored formazan dye 
that is soluble in cell culture media and can be quantified by measuring the absorbance at 490-500 
nm.  
 
3.2.1 Results  
The neuroprotective activity of flavones 5 and 6 and their monofluorinated derivatives 12 
and 13 in concentration ranging from (40 – 0.31 μM) were evaluated against glutamate by 
measuring the absorbance of the reduced form of TMS at 490 nm. The data indicates that the un-
fluorinated hydroxy flavones shows more neuroprotective activity than the monofluorinated 
hydroxy derivative. While the monofluorinated hydroxy derivative was more active then un-
fluorinated methoxy flavones (Figure 3.3). 
 
Figure 3.2: Structures of MTS   
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Figure 3.3: Neuroprotective assay results    
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CHAPTER 4 
CONCLUSION 
The synthesis of the desired flavones and their monofluorinated and trifluoromethylated 
derivative was successful. Pyridine was used in the key step to increase the yield 32% to 72% and 
reduce the reaction time from one week to 12 hours. The biological evaluation of the flavonoids 
was carried out by using two assays, DPPH antioxidant assay and MTS cell proliferation assay. 
DPPH antioxidant assay was preformed on the flavones and their monofluorinated flavones. The 
results indicate that the monofluorinated flavones are more potent than un-fluorinated flavones. 
Fluorinated and un-fluorinated flavones have potential neuroprotective activity. Using 19F NMR 
to understand the impact of fluorination on the antioxidant activity of flavones is still in progress. 
The preliminary data are not conclusive about the effect of fluorination and therefore more NMR 
experiments are required. 
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CHAPTER 5 
Experimental Details 
5.1 Synthesis of Flavonoids 
 
+  
 
2-Acetylphenyl 3,4,5-trimethoxybenzoate 3. A mixture of 1-(2-hydroxyphenyl)ethan-1-
one 1 (200 mg, 1.47 mmol) and 3,4,5-trimethoxybenzoyl chloride 2 (404 mg, 1.76 mmol) in 
pyridine (3 mL) was heated at 70 °C under air. After 12 h, the reaction mixture was cooled to 0 
°C, then acidified by adding 1 M of aqueous HCl (3 mL), and the resultant mixture was extracted 
with EtOAc (10 mL × 3). The organics were dried over Na2SO4 and concentrated under reduced 
pressure. SiO2 flash chromatography (7:3 hexanes/EtOAc) afforded the 2-acetylphenyl 3,4,5-
trimethoxybenzoate product 3 as a white solid (357 mg) in 73% yield: 1H NMR (400 MHz, 
CDCl3) δ 7.66 (dd, J = 7.8, 1.5 Hz, 1H), 7.39 (t, J = 8.5 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 7.06 
(s, 2H), 7.03 (d, J = 8.1 Hz, 1H), 3.74 (s, 6H), 3.73 (s, 3H), 2.35 (s, 3H).
32 
 
 
 
 
 
 
(Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 4. A 
mixture of 2-acetylphenyl 3,4,5-trimethoxybenzoate 3 (200 mg, 0.60 mmol) and potassium 
hydroxide (60 mg, 1.06 mmol) in pyridine (3 mL) was heated at 50 °C under air. After 12 h, the 
reaction mixture was cooled to 0 °C, then acidified by adding 1M of aqueous HCl (3 mL), and 
the resultant mixture was extracted with EtOAc (10 mL × 3). The organics were dried over 
Na2SO4 and concentrated under reduced pressure. SiO2 flash chromatography (7:3 
hexanes/EtOAc) afforded the (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-
trimethoxyphenyl)prop-2-en-1-one product 4 as a yellow solid (160 mg) in 81% yield: 1H NMR 
(500 MHz, CDCl3) δ 15.72 (s, 1H), 12.02 (s, 1H), 7.74 (d, J = 7.9 Hz, 1H), 7.43 (t, 1H), 7.13 (S, 
2H), 6.97 (d, J = 8.3 Hz, 1H), 6.89 (t, J = 7.5 Hz, 1H), 6.71 (s, 2H), 3.93 (s, 6H), 3.91 (s, 3H). 
 
 
2-(3,4,5-Trimethoxyphenyl)-4H-chromen-4-one 5. A mixture of (Z)-3-hydroxy-1-(2-
hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 4 (10 mg, 0.03 mmol) and iron(III) 
chloride (0.47 mg , 0.0087 mmol) in dichloromethane (1 mL)  was stirred at rt under air. After 24 
h, the reaction mixture was extracted with dichloromethane (1 mL × 3). The organics were dried 
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over Na2SO4 and concentrated under reduced pressure to afford the 2-(3,4,5-trimethoxyphenyl)-
4H-chromen-4-one  5 (8.3 mg) in 89% yield: 1H NMR (500 MHz, CDCl3) δ 8.24 (d, J = 7.9 Hz, 
1H), 7.72 (t, J = 7.7 Hz, 1H), 7.60 (d, J = 8.3 Hz, 1H), 7.44 (t, J = 7.3 Hz, 1H), 7.15 (s, 2H), 6.83 
(s, 1H), 3.97 (s, 6H), 3.94 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 178.32, 163.26, 156.24, 
153.64, 141.32, 133.77, 127.02, 125.72, 125.31, 123.96, 118.11, 107.40, 103.85, 77.48, 77.16, 
76.84, 61.08, 56.42. 
 
2-(3,4,5-Trihydroxyphenyl)-4H-chromen-4-one 6. A mixture of 2-(3,4,5-
trimethoxyphenyl)-4H-chromen-4-one 5 (10 mg, 0.03 mmol) in hydrobromic acid (1 mL) was 
stirred in a sealed tube at 100 °C. After 24 h, the reaction mixture was cooled to rt and 
concentrated under reduced pressure to afford the 2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one 
6 (8.1 mg) in quantitative yield: 1H NMR (400 MHz, acetone-d6) δ 8.10 (d, J = 7.5 Hz, 1H), 7.78 
(t, J = 8.4 Hz, 1H), 7.67 (d, J = 8.4 Hz, 1H), 7.46 (t, J = 7.4 Hz, 1H), 7.14 (s, 2H), 6.60 (s, 1H), 
2.80 (s, 3H); 13C NMR (101 MHz, DMSO) δ 176.93, 163.67, 155.64, 146.51, 137.80, 134.22, 
125.43, 124.83, 123.36, 120.79, 118.35, 105.81, 104.86, 40.15, 39.94, 39.73, 39.52, 39.31, 39.10, 
38.89. 
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5.2 Synthesis of Monofluorinated Flavonoids  
 
 
 
 
(E)-2-fluoro-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-
1-one 10. A mixture of (Z)-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-
en-1-one 4 (10 mg, 0.03 mmol), and N-fluorobenzenesulfonimide (11.88 mg, 0.036 mmol) in 
pyridine (1 mL) was stirred at rt under air. After 24 h, the reaction mixture was cooled to rt and 
water (2 mL) was added. The reaction mixture was cooled to 0 °C, then acidified by adding 2 M 
of aqueous HCl (3 mL), and the resultant mixture was extracted with Et2O (2 mL × 5). The 
organics were dried over Na2SO4 and concentrated under reduced pressure. SiO2 flash 
chromatography (7:3 hexanes/EtOAc) followed by prep. TLC by using (7:3 hexanes/EtOAc) to 
afforded the (E)-2-fluoro-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-
1-one 10 (5.89 mg) in 49% yield:  1H NMR (500 MHz, CDCl3) δ 15.72 (s, 1H), 12.02 (s, 1H), 
7.74 (d, J = 7.9 Hz, 1H), 7.43 (t, 1H), 7.13 (S, 2H), 6.97 (d, J = 8.3 Hz, 1H), 6.89 (t, J = 7.5 Hz, 
1H), 6.51 (d, J = 48.8 Hz, 1H), 3.93 (s, 6H), 3.91 (s, 3H);19F NMR (300 MHz, CDCl3) –186.17 
(d, J = 48.9 Hz)  
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3-Fluoro-2-(3,4,5-trimethoxyphenyl)- 4H-chromen-4-one 12. A mixture of (E)-2-
fluoro-3-hydroxy-1-(2-hydroxyphenyl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 10 (10 mg, 
0.0287 mmol), and iron(III) chloride (0.47 mg , 0.0087 mmol) in dichloromethane (1 mL)  was 
stirred at rt under air, after 24 h, the reaction mixture was extracted with dichloromethane (1 mL 
× 3). The organics were dried over Na2SO4 and concentrated under reduced pressure to afforded 
the 3-fluoro-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-one 12 (7.9 mg) in 84% yield: 1H NMR 
(500 MHz, CDCl3) δ 8.24 (d, J = 7.9 Hz, 1H), 7.72 (t, J = 7.7 Hz, 1H), 7.60 (d, J = 8.3 Hz, 1H), 
7.44 (t, J = 7.3 Hz, 1H), 7.15 (s, 2H), 3.97 (s, 6H), 3.94 (s, 3H); 13C NMR (101 MHz, 
Chloroform-d) δ 170.86 (d, J = 16.7 Hz), 150.78 (d, J = 23.2 Hz), 146.09 (d, J = 247.8 Hz), 
141.14 (d, J = 1.6 Hz), 125.98 (d, J = 3.3 Hz), 124.24 (d, J = 7.1 Hz), 123.86 (d, J = 5.1 Hz), 
105.81 (d, J = 8.5 Hz); 19F NMR (300 MHz, CDCl3) –160.36   
 
3-Fluoro-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one 13. A mixture of 3-fluoro-2-
(3,4,5-trimethoxyphenyl)-4H-chromen-4-one 12 (10 mg, 0.03 mmol) in hydrobromic acid (1 
mL) was stirred in a sealed tube. After 24 h, the reaction mixture was cooled to rt and 
concentrated under reduced pressure to afford the 3-fluoro-2-(3,4,5-trimethoxyphenyl)-4H-
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chromen-4-one 13 (8.6 mg) in quantitative yield: 1H NMR (400 MHz, DMSO-d6) δ 8.11 (d, J = 
9.0 Hz, 1H), 7.90–7.80 (m, 1H), 7.74 (d, J = 8.1 Hz, 3H), 7.58–7.46 (m, 2H), 7.07 (s, 2H), 3.90 
(s, 0H); 13C NMR (101 MHz, DMSO-d6) δ 169.42 (d, J = 16.8 Hz), 151.19 (d, J = 23.3 Hz), 
146.36–143.72 (m), 137.48 (d, J = 1.3 Hz), 124.91 (d, J = 3.4 Hz), 123.57 (d, J = 7.1 Hz), 117.85 
(d, J = 5.2 Hz), 107.40 (d, J = 8.5 Hz); 19F NMR (400 MHz, DMSO) δ –165.19 
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5.3 Synthesis of Trifluoromethylated Flavonoids 
 
3-(Trifluoromethyl)-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one 15. A mixture of 
2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one 5 (10 mg, 0.032 mmol), copper(I) iodide (0.6 mg, 
0.0032 mmol) and 5-(trifluoromethyl)dibenzothiophenium trifluoromethanesulfonate 
(Umemoto's reagent) (10 mg, 0.048 mmol) in DMF (1 mL) was heated at 80 °C under argon. 
After 34 h, the resultant mixture was extracted with diethyl ether (2 mL × 5). The organics were 
dried over Na2SO4 and concentrated under reduced pressure to afford the 3-(trifluoromethyl)-2-
(3,4,5-trihydroxyphenyl)-4H-chromen-4-one. 20% estimated 19F NMR yield; 1H NMR (500 
MHz, CDCl3) δ 8.24 (d, J = 7.9 Hz, 1H), 7.72 (t, J = 7.7 Hz, 1H), 7.60 (d, J = 8.3 Hz, 1H), 7.44 
(t, J = 7.3 Hz, 1H), 7.15 (s, 2H), 3.97 (s, 6H), 3.94 (s, 3H); 19F NMR (300 MHz, CDCl3) –56 (s, 
3F). 
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5.4 The DPPH antioxidant assay  
0.2 M stock solution of DPPH in 1:1 ethanol and acetone solution was prepared, and also, 
1 mg/mL stock solution of the flavones in 1:1 ethanol and acetone solution. The positive control 
was vitamin C and it was prepared with concertation of 1 mg/mL in 1:1 ethanol and acetone 
solution. All the stock solutions were prepared daily and stored in the refrigerator in dark. 
5.4.1 Preparation:   
Fill all the wells with 100 μL of (1:1) ethanol-acetone solution then add to ( A2 to A7 ) of 
the well 100 μL of the stock solution of the test flavones and prepare a serial dilution of (200, 100, 
50, 25, 12.5, 6.25 and 3.125 μg/mL) by using the appropriate size of micropipette moving from A 
to H as seen in (Table 5.1). Next add 100 μL of DPPH solution to all the wells except the blanks, 
the plate must be covered all time to minimize evaporation and kept away from light in room 
temperature and left for 20 minutes then measure the absorbance at 517 nm 
5.4.2 Calculation  
% DPPH scavenging = [1-(Abs Sample with DPPH–Abs Sample Blank)]/[(Abs DPPH) – 
(Abs Solvent)] x 100  
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 1 
 
Control 
2 
Sample 1    
(Blank) 
3 
Sample 1     
+ DPPH 
4 
Sample 1      
(Blank) 
5 
Sample 1         
+ DPPH 
6 
Sample 1         
(Blank) 
7 
Sample 1           
+ DPPH 
A DPPH 
0.1 
mM 
Sample 1 
200 
μg/mL 
Sample 1 
200 
μg/mL 
Sample 1 
200 
μg/mL 
Sample 1 
200 
μg/mL 
Sample 1 
200 
μg/mL 
Sample 1 
200 μg/mL 
B DPPH 
0.1 
mM 
Sample 1 
100 
μg/mL 
Sample 1 
100 
μg/mL 
Sample 1 
100 
μg/mL 
Sample 1 
100 
μg/mL 
Sample 1 
100 
μg/mL 
Sample 1 
100 μg/mL 
C DPPH 
0.1 
mM 
Sample 1 
50  
μg/mL 
Sample 1 
50  
μg/mL 
Sample 1 
50  
μg/mL 
Sample 1 
50  
μg/mL 
Sample 1 
50  μg/mL 
Sample 1 
50  μg/mL 
D DPPH 
0.1 
mM 
Sample 1 
25 
μg/mL 
Sample 1 
25 
μg/mL 
Sample 1 
25 
μg/mL 
Sample 1 
25 
μg/mL 
Sample 1 
25 μg/mL 
Sample 1 
25 μg/mL 
E DPPH 
0.1 
mM 
Sample 1 
12.5 
μg/mL 
Sample 1 
12.5 
μg/mL 
Sample 1 
12.5 
μg/mL 
Sample 1 
12.5 
μg/mL 
Sample 1 
12.5 
μg/mL 
Sample 1 
12.5 μg/mL 
F DPPH 
0.1 
mM 
Sample 1 
6.25 
μg/mL 
Sample 1 
6.25 
μg/mL 
Sample 1 
6.25 
μg/mL 
Sample 1 
6.25 
μg/mL 
Sample 1 
6.25 
μg/mL 
Sample 1 
6.25 μg/mL 
H DPPH 
0.1 
mM 
Sample 1 
3.125 
μg/mL 
Sample 1 
3.125 
μg/mL 
Sample 1 
3.125 
μg/mL 
Sample 1 
3.125 
μg/mL 
Sample 1 
3.125 
μg/mL 
Sample 1 
3.125 
μg/mL 
Table 5.1: 96-well plate arrangement 
 
Figure 5.1: Procedure for DPPH assay   
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5.5 Neuroprotective assay 
Before culturing the neurons, the 96-well plate was coated with 60 μL of 0.01% Poly-L-
Lysine and incubated for 24 hours then washed with distilled water. Next, the neurons were 
cultured in a 96-well plate with 100 μL growth media that include neurobasal media, L-
glutamine, fetal bovine serum (FBS), and Pen Strep and incubated for 24 hours. The growth 
media was replaced by a media that doesn’t contain the fetal bovine serum (FBS), and the plate 
was then incubated for one week. Next, it was treated with glutamate and the test compound. 
After 24 h the MTS assay was performed by using CellTiter 96 AQueous One Solution 
Reagent. 
 
Figure 5.2: Procedure for neuroprotective assay 
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